Πλοήγηση ανά Συγγραφέα "Kotsopoulou, M."

Αποτελέσματα 1-5 από 5

Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients

Katodritou, E.; Terpos, E.; Symeonidis, A. S.; Pouli, A.; Kelaidi, C.; Kyrtsonis, M. C.; Kotsopoulou, M.; Delimpasi, S.; Christoforidou, A.; Giannakoulas, N.; Viniou, N. A.; Stefanoudaki, E.; Hadjiaggelidou, C.; Christoulas, D.; Verrou, E.; Gastari, V.; Papadaki, S.; Polychronidou, G.; Papadopoulou, A.; Giannopoulou, E.; Kastritis, E.; Kouraklis, A.; Konstantinidou, P.; Anagnostopoulos, A.; Zervas, K.; Dimopoulos, M. A. (2014)

Solitary plasmacytoma (SP) is a rare plasma cell dyscrasia characterized by the presence of bone or extramedullary plasma cell tumors. The treatment of choice is local radiotherapy (R/T) +/- surgical excision. The role of ...
JAK2 V617F-POSITIVE CHRONIC EOSINOPHILIC LEUKEMIA: CLINICAL, LABORATORY AND MOLECULAR DEFINITION OF A DISTINCT DISEASE SUBTYPE

Zoi, K.; Dahabreh, I. J.; Zoi, C.; Helbig, G.; Krzemien, S.; Gota, V.; Speletas, M.; Giannouli, S.; Palliou, A.; Stefanoudaki, K.; Harhalakis, N.; Vassilopoulos, G.; Kotsopoulou, M.; Tsirigotis, P.; Moutsopoulos, H. M.; Loukopoulos, D.; Voulgarelis, M. (2009)
A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies

Gamaletsou, M. N.; Walsh, T. J.; Zaoutis, T.; Pagoni, M.; Kotsopoulou, M.; Voulgarelis, M.; Panayiotidis, P.; Vassilakopoulos, T.; Angelopoulou, M. K.; Marangos, M.; Spyridonidis, A.; Kofteridis, D.; Pouli, A.; Sotiropoulos, D.; Matsouka, P.; Argyropoulou, A.; Perloretzou, S.; Leckerman, K.; Manaka, A.; Oikonomopoulos, P.; Daikos, G.; Petrikkos, G.; Sipsas, N. V. (2014)

Invasive candidiasis is a life-threatening infection in patients with haematological malignancies. The objective of our study was to determine the incidence, microbiological characteristics and clinical outcome of candidaemia ...
Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group

Katodritou, E.; Terpos, E.; Kelaidi, C.; Kotsopoulou, M.; Delimpasi, S.; Kyrtsonis, M. C.; Symeonidis, A.; Giannakoulas, N.; Stefanoudaki, A.; Christoulas, D.; Chatziaggelidou, C.; Gastari, V.; Spyridis, N.; Verrou, E.; Konstantinidou, P.; Zervas, K.; Dimopoulos, M. A. (2014)

Plasma cell leukemia (PCL) is a rare and aggressive plasma cell disorder, with poor outcome. Bortezomib-based regimens (BBR) are highly effective in myeloma, but there is limited information about their efficacy and safety ...
Treatment with lenalidomide for patients with myelodysplastic syndromes (MDS): report of the Hellenic experience on 73 patients. A retrospective analysis of the Hellenic MDS Study Group

Symeonidis, A.; Galanopoulos, A.; Hatzimichael, E.; Kouraklis, A.; Korantzis, I.; Kartasis, Z.; Giannakoulas, N.; Michali, E.; Kokkini, G.; Vagia, M.; Kotsopoulou, M.; Pappa, V.; Papadaki, E.; Bourantas, K.; Matsouka, P.; Anagnostopoulos, N.; Zoumbos, N.; Hellenic, M. D. S. Study Grp (2009)

Πλοήγηση ανά Συγγραφέα "Kotsopoulou, M."

Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients ﻿

JAK2 V617F-POSITIVE CHRONIC EOSINOPHILIC LEUKEMIA: CLINICAL, LABORATORY AND MOLECULAR DEFINITION OF A DISTINCT DISEASE SUBTYPE ﻿

A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies ﻿

Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group ﻿

Treatment with lenalidomide for patients with myelodysplastic syndromes (MDS): report of the Hellenic experience on 73 patients. A retrospective analysis of the Hellenic MDS Study Group ﻿

Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients

JAK2 V617F-POSITIVE CHRONIC EOSINOPHILIC LEUKEMIA: CLINICAL, LABORATORY AND MOLECULAR DEFINITION OF A DISTINCT DISEASE SUBTYPE

A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies

Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group

Treatment with lenalidomide for patients with myelodysplastic syndromes (MDS): report of the Hellenic experience on 73 patients. A retrospective analysis of the Hellenic MDS Study Group